SCHEMBL14720563

SCHEMBL14720563

CC(=O)NC1CCC(O)(c2ccc(C=C3CCN(C4CCC4)CC3)cc2)CC1

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 3/20 0.36
OPRD1 P41143 3/20 0.36
OPRK1 P41145 3/20 0.36
OGFRL1 Q5TC84 3/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
POLB P06746 1/20 0.35
TSHR P16473 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
ATM Q13315 1/20 0.35
SRD5A2 P31213 2/20 0.35
ALOX15 P16050 1/20 0.34
ALDH1A1 P00352 1/20 0.34
CCR1 P32246 6/20 0.34
TACR1 P25103 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14723376 0.84 MEN1 (0.42) MEN1KMT2ASRD5A2ALDH1A1CCR1
SCHEMBL14721332 0.83 HRH3 (0.39) OPRM1MEN1KMT2ASRD5A2CCR1
SCHEMBL14721633 0.82 HRH3 (0.36) OPRM1OPRK1MEN1KMT2ACCR1
SCHEMBL14720774 0.82 HRH3 (0.40) OPRM1MEN1KMT2ASRD5A2CCR1
SCHEMBL14731164 0.82 SRD5A2 (0.34) OPRM1OPRD1OPRK1SRD5A2ALOX15
SCHEMBL14720493 0.81 MEN1 (0.35) MEN1KMT2ASRD5A2CCR1
SCHEMBL14721195 0.81 MEN1 (0.40) MEN1KMT2ASRD5A2ALDH1A1CCR1
SCHEMBL14720519 0.81 HRH3 (0.34) CCR1
SCHEMBL14731091 0.79 OPRM1 (0.35) OPRM1MEN1KMT2ASRD5A2CCR1
SCHEMBL14720746 0.79 HRH3 (0.38) MEN1KMT2ACCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO claimed
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed